» Articles » PMID: 33935650

Stem Cell-Based Therapy for Experimental Ischemic Stroke: A Preclinical Systematic Review

Overview
Specialty Cell Biology
Date 2021 May 3
PMID 33935650
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Stem cell transplantation offers promise in the treatment of ischemic stroke. Here we utilized systematic review, meta-analysis, and meta-regression to study the biological effect of stem cell treatments in animal models of ischemic stroke. A total of 98 eligible publications were included by searching PubMed, EMBASE, and Web of Science from inception to August 1, 2020. There are about 141 comparisons, involving 5,200 animals, that examined the effect of stem cell transplantation on neurological function and infarct volume as primary outcome measures in animal models for stroke. Stem cell-based therapy can improve both neurological function (effect size, -3.37; 95% confidence interval, -3.83 to -2.90) and infarct volume (effect size, -11.37; 95% confidence interval, -12.89 to -9.85) compared with controls. These results suggest that stem cell therapy could improve neurological function deficits and infarct volume, exerting potential neuroprotective effect for experimental ischemic stroke, but further clinical studies are still needed.

Citing Articles

Brain repair mechanisms after cell therapy for stroke.

Rust R, Nih L, Liberale L, Yin H, El Amki M, Ong L Brain. 2024; 147(10):3286-3305.

PMID: 38916992 PMC: 11449145. DOI: 10.1093/brain/awae204.


Estimation of the Ischemic Lesion in the Experimental Stroke Studies Using Magnetic Resonance Imaging (Review).

Namestnikova D, Cherkashova E, Gumin I, Chekhonin V, Yarygin K, Gubskiy I Bull Exp Biol Med. 2024; 176(5):649-657.

PMID: 38733482 DOI: 10.1007/s10517-024-06086-z.


Comparative study of the efficacy of intra-arterial and intravenous transplantation of human induced pluripotent stem cells-derived neural progenitor cells in experimental stroke.

Cherkashova E, Namestnikova D, Leonov G, Gubskiy I, Sukhinich K, Melnikov P PeerJ. 2023; 11:e16358.

PMID: 38025691 PMC: 10640846. DOI: 10.7717/peerj.16358.


Targeting Neurogenesis in Seeking Novel Treatments for Ischemic Stroke.

Nagase T, Kin K, Yasuhara T Biomedicines. 2023; 11(10).

PMID: 37893146 PMC: 10604112. DOI: 10.3390/biomedicines11102773.


A review and meta-analysis of stem cell therapies in stroke patients: effectiveness and safety evaluation.

Hovhannisyan L, Khachatryan S, Khamperyan A, Matinyan S Neurol Sci. 2023; 45(1):65-74.

PMID: 37733251 PMC: 10761518. DOI: 10.1007/s10072-023-07032-z.


References
1.
Thorne R, Frey 2nd W . Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations. Clin Pharmacokinet. 2001; 40(12):907-46. DOI: 10.2165/00003088-200140120-00003. View

2.
Bond A, Ming G, Song H . Adult Mammalian Neural Stem Cells and Neurogenesis: Five Decades Later. Cell Stem Cell. 2015; 17(4):385-95. PMC: 4683085. DOI: 10.1016/j.stem.2015.09.003. View

3.
Gutierrez-Fernandez M, Rodriguez-Frutos B, Alvarez-Grech J, Vallejo-Cremades M, Exposito-Alcaide M, Merino J . Functional recovery after hematic administration of allogenic mesenchymal stem cells in acute ischemic stroke in rats. Neuroscience. 2010; 175:394-405. DOI: 10.1016/j.neuroscience.2010.11.054. View

4.
Su H, Zhang W, Guo J, Guo A, Yuan Q, Wu W . Neural progenitor cells enhance the survival and axonal regeneration of injured motoneurons after transplantation into the avulsed ventral horn of adult rats. J Neurotrauma. 2009; 26(1):67-80. DOI: 10.1089/neu.2008.0656. View

5.
Abd El Motteleb D, Hussein S, Hasan M, Mosaad H . Comparison between the effect of human Wharton's jelly-derived mesenchymal stem cells and levetiracetam on brain infarcts in rats. J Cell Biochem. 2018; 119(12):9790-9800. DOI: 10.1002/jcb.27297. View